Register Login

Avadel Pharmaceuticals (AVDL)

  • SEC News
  • Aug. 07, 2025, 11:08 UTC
  • 2
  • 0 comments

New Form 8-K - AVADEL PHARMACEUTICALS PLC Filed: 2025-08-07 AccNo: 0001104659-25-074965 Size: 333 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Akebia Therapeutics Inc (AKBA)

  • SEC News
  • Aug. 07, 2025, 11:06 UTC
  • 2
  • 0 comments

New Form 8-K - Akebia Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001517022-25-000034 Size: 264 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Phathom Pharmaceuticals Inc (PHAT)

  • SEC News
  • Aug. 07, 2025, 11:06 UTC
  • 2
  • 0 comments

New Form 8-K - Phathom Pharmaceuticals, Inc. Filed: 2025-08-07 AccNo: 0001193125-25-174943 Size: 237 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Cartesian Therapeutics Inc (RNAC)

  • SEC News
  • Aug. 07, 2025, 11:06 UTC
  • 2
  • 0 comments

New Form 8-K - Cartesian Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001453687-25-000098 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

Eli Lilly and Company (LLY)

  • SEC News
  • Aug. 07, 2025, 11:06 UTC
  • 2
  • 0 comments

New Form 8-K - ELI LILLY & Co Filed: 2025-08-07 AccNo: 0000059478-25-000202 Size: 500 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Comment Full text

C4 Therapeutics Inc (CCCC)

  • SEC News
  • Aug. 07, 2025, 11:05 UTC
  • 2
  • 0 comments

New Form 8-K - C4 Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0001628280-25-038576 Size: 3 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Comment Full text

Cullinan Oncology Inc (CGEM)

  • SEC News
  • Aug. 07, 2025, 11:05 UTC
  • 2
  • 0 comments

New Form 8-K - Cullinan Therapeutics, Inc. Filed: 2025-08-07 AccNo: 0000950170-25-104547 Size: 398 KB Item 2.02: Results of Operations and Financial Condition Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

Comment Full text

Search

News categories